Varex Imaging Corp (VREX)
- Sector
- Health Care
- Last price
- $18.47
- As of
Kresmion compiles this page from VREX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Varex Imaging Corp (VREX): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-10.
See the full VREX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VREX on one page. Preview it with sample data, then open it live with a free account.
Preview the VREX dossierActive signals for VREX
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +247132% to VREX (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +158% to VREX (2026Q2)
- mediumEARNINGS_BEAT
Q3-2026: Beat consensus by 44.9%, EPS $0.31 vs $0.2139 estimate
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 57% of VREX (2026Q1)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 66% of VREX (2026Q1)
FREE, NO ACCOUNT
Every signal on VREX, as it fires
You are seeing 5 of 9 signals recorded on VREX since 2026-05-17.
The five above landed across 3 days. The other 4 were recorded on 1 other days. 5 of the 9 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in VREX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 92214X106 · 2026Q2 | $9.7M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 92214X106 · 2026Q2 | $4.8M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 92214X106 · 2026Q2 | $3.7M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 92214X106 · 2026Q2 | $2.7M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 92214X106 · 2026Q2 | $1.8M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 92214X106 · 2026Q2 | $1.4M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, VREX
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
VREX against its peers
VREX's operating margin of -3.3% ranks in the 46th percentile of 24 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-01-02.
| Metric | VREX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 845M USD | 675M USD | 58 | 24 |
| Gross margin | 34.4% | 63.7% | 21 | 11 |
| Operating margin | -3.3% | -0.3% | 46 | 24 |
| Net margin | -8.3% | -4.2% | 34 | 24 |
| Return on equity | -14.9% | -5.1% | 35 | 23 |
| P / E | n/a | 47.8x | n/a | 7 |
| 1 year | 64.2% | -2.7% | 79 | 20 |
Peers (24): AHCO, TALK, EHAB, BVS, CSTL, HSTM, FLGT, TDOC, STAA, IRMD, PRCT, GDRX, TNDM, USPH, EVH, OMDA, CNMD, SGHT, CERS, CERT, PNTG, AMN, CCRN, CTEV. Left out: ANGO (period gap). Fiscal periods ending between 2025-10-03 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (VREX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow VREX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to VREX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.